ACTA1 and chronic kidney disease: Western blotting revealed higher levels of FN, Col-IV, α-SMA, and vimentin in the CKD group in contrast to the control group (p < 0.001), while administration of JPYSF markedly lowered these proteins expression in CKD mice (p < 0.05, Figure 3A–3E).